Table 3.
Frequency of selected outcomes for scorpion envenomation reported by decade of age. Percentages are relative to total exposures in each age group
| Age range (Yrs) | Total exposures | Major effects | Hospitalizations | Benzodiazepines administered | Antivenom administered | Intubations performed | ||
|---|---|---|---|---|---|---|---|---|
| Non-ICU | ICU | Total | ||||||
| 0–9 | 28,192 | 184 (0.65%) | 120 (0.43%) | 465 (1.6%) | 585 (2.1%) | 993 (3.5%) | 2376 (8.4%) | 139 (0.49%) |
| 10–19 | 24,882 | 18 (0.07%) | 41 (0.16%) | 34 (0.14%) | 75 (0.30%) | 216 (0.87%) | 252 (1.0%) | – |
| 20–29 | 25,860 | 8 (0.03%) | 55 (0.21%) | 23 (0.09%) | 78 (0.30%) | 156 (0.60%) | 98 (0.38%) | 1 (0.00%) |
| 30–39 | 25,799 | 10 (0.04%) | 49 (0.19%) | 25 (0.10%) | 74 (0.29%) | 183 (0.71%) | 91 (0.35%) | 2 (0.01%) |
| 40–49 | 23,536 | 10 (0.04%) | 39 (0.17%) | 21 (0.09%) | 60 (0.25%) | 183 (0.78%) | 112 (0.48%) | 2 (0.01%) |
| 50–59 | 20,824 | 10 (0.05%) | 45 (0.22%) | 30 (0.14%) | 75 (0.36%) | 249 (1.2%) | 127 (0.61%) | 3 (0.01%) |
| 60–69 | 14,115 | 15 (0.11%) | 64 (0.45%) | 23 (0.16%) | 87 (0.62%) | 177 (1.3%) | 131 (0.93%) | 4 (0.03%) |
| 70–79 | 6819 | 11 (0.16%) | 41 (0.60%) | 28 (0.41%) | 69 (1.0%) | 119 (1.7%) | 88 (1.3%) | 5 (0.07%) |
| ≥80 | 2886 | – | 23 (0.80%) | 12 (0.42%) | 35 (1.2%) | 53 (1.8%) | 45 (1.6%) | 1 (0.03%) |
| Unknown | 12,489 | 10 (0.08%) | 9 (0.07%) | 2 (0.02%) | 11 (0.09%) | 19 (0.15%) | 36 (0.29%) | – |
| Total | 185,402 | 276 (0.15%) | 486 (0.26%) | 663 (0.36%) | 1149 (0.62%) | 2348 (1.3%) | 3356 (1.8%) | 157 (0.08%) |